| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/25/2010 | US20100076175 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs |
| 03/25/2010 | US20100076174 ErbB Interface Peptidomimetics And Methods Of Use Thereof |
| 03/25/2010 | US20100076112 Crosslinkable pressure-sensitive adhesive for skin |
| 03/25/2010 | US20100076094 Formulation containing phosphate derivatives of electron transfer agents |
| 03/25/2010 | US20100076093 Use of ergothioneine as a preservative in foods and beverages |
| 03/25/2010 | US20100076092 Lipid-derived nanoparticles for brain-targeted drug delivery |
| 03/25/2010 | US20100076067 Biodegradable block copolymeric compositions for drug delivery |
| 03/25/2010 | US20100076008 Pharmaceutical compositions containing plasma protein |
| 03/25/2010 | US20100075927 Chemotherapeutic conjugates and methods of use |
| 03/25/2010 | US20100075850 Agrochemical Formulations Comprising N-vinylamid Co-polymers |
| 03/25/2010 | US20100075849 Agrochemical Formulations Comprising 1-vinyl-2-pyrrolidinone Co-Polymers |
| 03/25/2010 | US20100074959 Lipid growth factor formulations |
| 03/25/2010 | US20100074952 Tasted masked veterinary solid compositions |
| 03/25/2010 | US20100074940 Linear polyesteramides from aminophenolic esters |
| 03/25/2010 | US20100074937 Polyanhydrides with therapeutically useful degradation products |
| 03/25/2010 | US20100074927 Delivery of therapeutic compounds via microparticles or microbubbles |
| 03/25/2010 | DE102008047910A1 Tablettierhilfsstoff auf Laktose- und Cellulosebasis Tabletting excipient on lactose and cellulose |
| 03/25/2010 | CA2833960A1 Linear polyesteramides from aminophenolic esters |
| 03/25/2010 | CA2738707A1 Method for the preparation of a controlled release system |
| 03/25/2010 | CA2737543A1 Composite organic compound powder for medical use and production method and suspension of the same |
| 03/25/2010 | CA2737463A1 Freeze-dried powder preparation of tetrodotoxin and the producing method thereof |
| 03/25/2010 | CA2737380A1 Tabletting excipient based on lactose and cellulose |
| 03/25/2010 | CA2737040A1 Polymer conjugates of therapeutic peptides |
| 03/25/2010 | CA2736864A1 Stable liquid antibody formulation |
| 03/25/2010 | CA2736106A1 Stabilized pharmaceutical sub-micron suspensions and methods of forming same |
| 03/25/2010 | CA2734333A1 Pegylated opioids with low potential for abuse |
| 03/25/2010 | CA2702604A1 Transdermal drug delivery using an osmolyte and vasoactive agent |
| 03/24/2010 | EP2165703A2 Direct compression formulation and process |
| 03/24/2010 | EP2164989A1 Targeted carriers for intracellular drug delivery |
| 03/24/2010 | EP2164968A2 Peg-pei copolymers for nucleic acid delivery |
| 03/24/2010 | EP2164875A1 Intranuclear protein transduction through a nucleoside salvage pathway |
| 03/24/2010 | EP2164874A1 Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity |
| 03/24/2010 | EP2164873A1 Stable igg4 antibodies |
| 03/24/2010 | EP2164866A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
| 03/24/2010 | EP2164861A1 Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
| 03/24/2010 | EP2164859A2 Methods and compositions involving polymeric immunoglobulin fusion proteins |
| 03/24/2010 | EP2164631A1 Modifying drug release in suspensions of ionic resin systems |
| 03/24/2010 | EP2164521A2 Glycoconjugates and use thereof as vaccine against<i>shigella flexneri</i>serotype 3a and x |
| 03/24/2010 | EP2164519A2 Long-acting polymeric prodrugs of exendin |
| 03/24/2010 | EP2164518A1 Formulations for the oral administration of therapeutic agents and related methods |
| 03/24/2010 | EP2164475A2 Therapeutic stable nanoparticles |
| 03/24/2010 | EP2164467A2 Slow release pharmaceutical composition made of microparticles |
| 03/24/2010 | EP2164466A1 Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier |
| 03/24/2010 | EP2164465A1 Self-emulsifying formulation of tipranavir for oral administration |
| 03/24/2010 | EP2164463A1 Concentrate esmolol |
| 03/24/2010 | EP2164461A1 Pharmaceutical formulation for the production of chewable tablets and lozenges |
| 03/24/2010 | EP2164460A1 Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 03/24/2010 | EP2164459A1 Stable non-aqueous pharmaceutical compositions |
| 03/24/2010 | EP2164458A1 Stable non-aqueous pharmaceutical compositions |
| 03/24/2010 | EP1915412B1 Method for preparing polymer maleimides |
| 03/24/2010 | EP1581583B1 Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles |
| 03/24/2010 | EP1507562B1 Compositions for radioimmunotherapy of brain |
| 03/24/2010 | EP1315506B1 Phospholipid derivatives of valproic acid and mixtures thereof |
| 03/24/2010 | EP1075496B1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
| 03/24/2010 | EP1003370B1 Method of enhancing magnesium absorption and prevention of atherosclerosis |
| 03/24/2010 | CN201426857Y Amoxicillin long-acting granular pill |
| 03/24/2010 | CN201426856Y Tilmicosin enteric coated granule |
| 03/24/2010 | CN201426855Y Florfenicol enteric coated granule |
| 03/24/2010 | CN101679948A Cell culture system |
| 03/24/2010 | CN101679526A Humanized and chimeric anti-TROP-2 antibodies that mediate cancer cell cytotoxicity |
| 03/24/2010 | CN101678125A Novel formulations for delivery of antiviral peptide therapeutics |
| 03/24/2010 | CN101678124A Binding ligand linked drug delivery conjugates of tubulysins |
| 03/24/2010 | CN101678123A Compositions that include a hydrophobic compound and a polyamino acid conjugate |
| 03/24/2010 | CN101678122A methods of reducing nephrotoxicity in subjects administered with nucleoside |
| 03/24/2010 | CN101678121A Modified hydroxypolymer conjugates with killing effect on tumor cells |
| 03/24/2010 | CN101678120A Prodrugs and methods of making and using the same |
| 03/24/2010 | CN101678119A Von willebrand factor- and factor VIII-polymer conjugates having a releasable linkage |
| 03/24/2010 | CN101678118A Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 03/24/2010 | CN101678117A Methods and compositions for gene therapy |
| 03/24/2010 | CN101678116A Sialoadhesin-related compositions and methods |
| 03/24/2010 | CN101678115A Pharmaceutical composition comprising porous dry matrix |
| 03/24/2010 | CN101678114A Solid dosage forms |
| 03/24/2010 | CN101678113A Low-molecule drug-containing nanoparticle having sustained release negatively charged group |
| 03/24/2010 | CN101678112A Methods and compositions for the delivery of a therapeutic agent |
| 03/24/2010 | CN101678111A Colored esmolol concentrate |
| 03/24/2010 | CN101678110A Solid dialysis preparation |
| 03/24/2010 | CN101678109A formulations of deacetylase inhibitors |
| 03/24/2010 | CN101678097A Vaccination regimen for b-cell vaccines |
| 03/24/2010 | CN101678094A formulation of meningitis vaccines |
| 03/24/2010 | CN101678086A 固体纤维蛋白原制剂 The solid fibrinogen preparation |
| 03/24/2010 | CN101678044A Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use |
| 03/24/2010 | CN101678042A Suspension for visualization of transparent tissue in eye |
| 03/24/2010 | CN101678025A Tetrahydrobiopterin compositions, and methods of measuring |
| 03/24/2010 | CN101677994A Melatonin tablet and methods of preparation and use |
| 03/24/2010 | CN101677959A Slow release pharmaceutical composition made of microparticles |
| 03/24/2010 | CN101677958A Oral pharmaceutical preparation for colon-specific delivery |
| 03/24/2010 | CN101677953A Terbinafine formulation for iontophoresis |
| 03/24/2010 | CN101677952A Improved depot formulations |
| 03/24/2010 | CN101677947A pharmaceutical formulation comprising an insulin derivative |
| 03/24/2010 | CN101677944A Stable non-aqueous pharmaceutical compositions |
| 03/24/2010 | CN101677941A Aqueous pharmaceutical preparation |
| 03/24/2010 | CN101677940A Composition for combating epistaxis |
| 03/24/2010 | CN101677926A Lipid composition having excellent shape retention property and product |
| 03/24/2010 | CN101677602A Natural honey-containing compositions and method of preparation |
| 03/24/2010 | CN101675996A Chitosan nano-microspheres product and preparation method thereof |
| 03/24/2010 | CN101675995A 10-hydroxycamptothecinreagent-delivery lipid ultrasound microbubble agent and its preparation method |
| 03/24/2010 | CN101675994A Therapy vaccine preparation |
| 03/24/2010 | CN101675993A melan-a peptide analogue-virus-like-particle conjugates |
| 03/24/2010 | CN101675991A Liquid composition of modified factor vii polypeptides |
| 03/24/2010 | CN101675919A Sustained release tablet of intestinal tract flora metabolite 20(s)-ppt containing ginsenoside Rg1 |